# Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism Prophylaxis

> **NCT07716332** · NA · NOT_YET_RECRUITING · sponsor: **Ron Beloosesky MD** · enrollment: 150 (estimated)

## Conditions studied

- Postpartum
- DVT Prophylaxis

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT07716332
- **Lead sponsor:** Ron Beloosesky MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07716332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07716332, "Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism Prophylaxis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07716332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*